Zdraveski Zoran

See RemarksTScan Therapeutics, Inc. (TCRX) · full profile →Form 4 · filed Aug 27, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$952K
Net Open-Market Flow
-$952K
Transactions
9
5 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 23, 2024Sell(S)165K$5.78$952K5K
Aug 23, 2024Option exercise(M)64K$2.49$160K169K
Aug 23, 2024Option exercise(M)13K$1.81$24K105K
Aug 23, 2024Option exercise(M)25K$3.27$82K92K
Aug 23, 2024Option exercise(M)55K$4.85$266K67K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 23, 2024Option exercise(M)64K$0366K
Aug 23, 2024Option exercise(M)25K$025K
Aug 23, 2024Option exercise(M)55K$030K
Aug 23, 2024Option exercise(M)13K$022K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-101161) within minutes of acceptance. Every field above traces to the original document. Verify it directly: